150517-75-2 Usage
Uses
Used in Pharmaceutical Research and Development:
2-FLUORO-6-METHOXYBENZYLAMINE is used as a key intermediate in the synthesis of pharmaceutical drugs for its ability to readily react with other compounds, facilitating the development of new and effective medications.
Used in Organic Synthesis:
In the field of organic synthesis, 2-FLUORO-6-METHOXYBENZYLAMINE is employed as a versatile building block, contributing to the creation of a diverse range of chemical compounds for various applications.
Used in Agrochemical Production:
2-FLUORO-6-METHOXYBENZYLAMINE is used as a component in the production of agrochemicals, where its reactivity aids in the synthesis of compounds designed to protect crops and enhance agricultural productivity.
Used in Specialty Chemicals Manufacturing:
2-FLUORO-6-METHOXYBENZYLAMINE also finds application in the manufacturing of specialty chemicals, where its unique properties are harnessed to produce high-value products for specific industries.
Check Digit Verification of cas no
The CAS Registry Mumber 150517-75-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,0,5,1 and 7 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 150517-75:
(8*1)+(7*5)+(6*0)+(5*5)+(4*1)+(3*7)+(2*7)+(1*5)=112
112 % 10 = 2
So 150517-75-2 is a valid CAS Registry Number.
InChI:InChI=1/C8H10FNO/c1-11-8-4-2-3-7(9)6(8)5-10/h2-4H,5,10H2,1H3
150517-75-2Relevant academic research and scientific papers
TRIAZOLOPYRIDINE COMPOUNDS AND USES THEREOF
-
Paragraph 00154, (2018/04/11)
A compound of Formula (IA), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein A, R6, R7 and R8 are as defined herein.
IMIDAZOPYRIMIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF CANCER
-
Paragraph 00149, (2018/04/12)
A compound of Formula (IA), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein A, R3, R4, R6, and R7 are as defined herein.
TROPANE COMPOUNDS
-
Page/Page column 373, (2009/05/30)
A compound according to Formula I or II: (I) or (II) wherein R1, R1b, R2, L1, and L2 and L2b are as defined in the specification, pharmaceutical compositions thereof, and methods of use thereof.
